Brief: Xlife Sciences AG Says Veraxa Biotech AG To Merge With Voyager Acquisition Corp.
23/04/2025 06:07
April 23 (Reuters) - Xlife Sciences AG XLS.S: FROM LAB TO UNICORN: XLIFE SCIENCES AG PORTFOLIO COMPANY VERAXA BIOTECH AG TO MERGE WITH VOYAGER ACQUISITION CORP. LISTED ON NASDAQ XLIFE SCIENCES AG - TRANSACTION VALUES VERAXA BIOTECH AT USD 1.64 BILLION XLIFE SCIENCES AG - VERAXA SHAREHOLDERS TO RECEIVE 130 MILLION SHARES XLIFE SCIENCES AG - BUSINESS COMBINATION EXPECTED TO CLOSE IN Q4 2025 XLIFE SCIENCES AG - VERAXA TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL VERX XLIFE SCIENCES AG - VERAXA IS RAISING A CROSSOVER FINANCING ROUND FROM NEW AND EXISTING INVESTORS XLIFE SCIENCES - PROCEEDS ARE EXPECTED TO PROVIDE CAPITAL FOR AT LEAST TWO YEARS AND SUPPORT PURSUIT OF KEY PARTNERSHIPS; CO-DEVELOPMENT OPPORTUNITIES Source text: ID:nEQ4z6W6ba Further company coverage: XLS.S ((Reuters.Briefs@thomsonreuters.com;))